Enanta Pharmaceuticals, based in Watertown, Massachusetts, focuses on developing small molecule drugs for viral infections and liver diseases, including treatments for RSV and hepatitis C. The company went public in March 2013 and employs 145 people.
Tara Lynn Kieffer sold 2,106 shares of ENTA on 5 December at $14.23 per share, worth a total of $30K. They now own 30,620 ENTA shares, or a 6% holding decrease.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.